Literature DB >> 10435150

Multiple primary tumours in patients with oral squamous cell carcinoma.

F Cianfriglia1, D A Di Gregorio, A Manieri.   

Abstract

A series of patients with oral squamous cell carcinoma (SCC) observed at the "Regina Elena" Cancer Institute was retrospectively reviewed in order to analyse the risk factors for multiple and second primary tumours (SPTs), their impact on survival and effective measures to control this phenomenon. In a survey of 200 individuals with a median follow-up of 3.2 years (25th percentile: 1.2, 75th percentile: 5.5), the incidence rate of SPTs was 14%: 39% arose in the oral cavity, 18% in the oropharynx, 10% in the lung and 7% both in the lip and larynx. There were no cases of secondary oesophageal tumours. Ninety-six per cent of the diagnosed histological types of SPTs were SCCs. Forty per cent of the new cancers were synchronous and 60% were metachronous, developing at a steady rate of 1.5% per year with no evidence of plateau. The overall incidence, adjusted by the length of follow-up, was 40 SPTs per 1000 person-years of follow-up. Although all the patients were at a greater risk for SPTs, the rates widely varied, according to specific factors: heavy tobacco consumption accounted for a statistically significant risk excess which was particularly high among younger smokers with an index tumour of the lower oral cavity. No difference was noticed in relation to the index neoplasm stage. In patients both with localised and advanced index tumours, 5-year survival rates were lower in those with SPTs and the difference was statistically significant for the 2-year survivors who were most likely to overcome the first disease. The present study confirms, the exceptionally high incidence of multifocal SCC in oral cancer patients and emphasizes the importance of preventive measures, since careful screening procedures, carried out to detect multifocal tumours at an early stage, should improve survival in these patients.

Entities:  

Mesh:

Year:  1999        PMID: 10435150     DOI: 10.1016/s1368-8375(98)00105-5

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Histomorphometric study to compare histological changes between oral squamous cell carcinoma and apparently normal adjacent oral mucosa.

Authors:  Deepa V Babji; Alka D Kale; Seema R Hallikerimath; Vijayalakshmi S Kotrashetti
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-05-18

2.  [Synchronous carcinoma of the floor of mouth carcinoma with esophageal carcinoma: a case report].

Authors:  Su Hua; Guo Xincheng; Wang Haiqing
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-10-01

3.  Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity.

Authors:  Feng-Yuan Liu; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-26       Impact factor: 9.236

4.  Compliance with quality assurance measures in patients treated for early oral tongue cancer.

Authors:  Amy C Hessel; Mauricio A Moreno; Ehab Y Hanna; Dianna B Roberts; Jan S Lewin; Adel K El-Naggar; David I Rosenthal; Randal S Weber
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

5.  Clinical features of multiple primary carcinomas of the oral cavity.

Authors:  Ya-Dong Li; Xin Ma; Yao-Lun Han; Li-Wei Peng
Journal:  Exp Ther Med       Date:  2016-12-27       Impact factor: 2.447

Review 6.  Oral field cancerization: current evidence and future perspectives.

Authors:  Punnya V Angadi; J K Savitha; Sanjay S Rao; Y Sivaranjini
Journal:  Oral Maxillofac Surg       Date:  2012-02-22

Review 7.  Field defects in progression to gastrointestinal tract cancers.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Katerina Dvorak; Harinder Garewal
Journal:  Cancer Lett       Date:  2007-12-31       Impact factor: 8.679

Review 8.  Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine.

Authors:  M Bryant Howren; Alan J Christensen; Lucy Hynds Karnell; Gerry F Funk
Journal:  J Consult Clin Psychol       Date:  2012-09-10

9.  PTEN deficiency contributes to the development and progression of head and neck cancer.

Authors:  Cristiane H Squarize; Rogerio M Castilho; Aline C Abrahao; Alfredo Molinolo; Mark W Lingen; J Silvio Gutkind
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

10.  Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).

Authors:  Belal M Azab; Rupesh Dash; Swadesh K Das; Sujit K Bhutia; Siddik Sarkar; Xue-Ning Shen; Bridget A Quinn; Paul Dent; Igor P Dmitriev; Xiang-Yang Wang; David T Curiel; Maurizio Pellecchia; John C Reed; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2014-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.